In addition to the need to conserve existing antibiotics, it is critical to develop new antibiotics which address the current and future unmet need, and are affordable and accessible to everyone as well. But the existing antibiotic pipeline is weak and holds limited promise for future treatment options.
Our recent assessment has shown that globally, big pharmaceutical companies have left the space of antibiotic research and development. On the other hand, small and medium scale companies are facing challenges and ongoing initiatives to promote innovation are less than adequate. It is clear that reforms are needed to rejuvenate the antibiotic innovation ecosystem for a sustainable and equitable antibiotic access. We had suggested that should include, greater public financing, coordinated global response from governments, right balance b/w publicprivate partnerships. We had also suggested that it is time to discuss if antibiotics can be considered as a ‘global public good’.
Our findings and suggestions have been discussed with global and national experts as part of our series – The Antibiotic Webinars. It became clear that antibiotic access needs to be integrated into reforms; the need for coordination, collaboration and prioritisation is much greater; nonfinancing measures can play an important role; and there are challenges as well as possibilities of considering antibiotics/any aspect of AMR response as a ‘global public good’, which will be presented in detail during the webinar.
We bring you our final webinar in “The Antibiotic Webinars’ series.
Please note: This is a free Zoom webinar, and registration is open to all. All those who register will receive an automatic confirmation. However, the webinar can accommodate a limited number of attendees on a first come-first served basis only. Therefore, please try to join 5 minutes before the scheduled time.
FOR MORE DETAILS, CONTACT
+91 88168 18864
|The crisis of antibiotic research and development|
|Rejuvenating the Global Antibiotic Innovation Ecosystem
By:Amit Khurana, Director, Sustainable Food Systems programme, CSE
|DTE: Cover Story|
|A Developing Crisis
July 16-31, 2023
Centre for Science and Environment
Quadripartite Joint Secretariat on AMR Division of Antimicrobial Resistance World Health Organisation, Switzerland
CEO & MD
Bugworks Research Inc, India
Infectious Disease team
Wellcome Trust, United Kingdom
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARBX), USA
Sustainable Food Systems programme CSE, New Delhi
Sustainable Food Systems Programme
Sustainable Food Systems Programme, CSE